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ABSTRACT
Recent animal studies and clinical trials have reported the scope of heart-resident ckit-
positive stem cells in regenerating infarcted myocardium. The determinants of
successful isolation of such cells are unknown. The objective of this study was to
determine the influence of risk factors for coronary artery disease and disease severity
on the successful isolation of ckit-positive cells from right atrial tissue of patients with
coronary artery disease. The findings suggest that coronary artery disease and cardiac
remodeling in chronic ischemia may not affect the yield of ckit-positive cells from
atrial tissue, but a significant negative correlation between the age of the patient and
the number of migrated ckit-positive cells was observed. This suggests that in older
patients, stem cell isolation from cardiac biopsies may not succeed, and such cells may
not be available for cell therapy.
(Asian Cardiovasc Thorac Ann 2009;17:139–42)
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INTRODUCTION
Beltrami and colleagues1 demonstrated the presence of
ckit-positive cells in postnatal hearts. Subsequently, they
provided evidence that this subpopulation of cells can be
isolated from mouse heart, grown in vitro in sufficient
numbers, and injected into mouse heart to repopulate
infarcted regions of the myocardium with cardiocytes
and blood vessels.2 Recently, stem cells have been
isolated from endomyocardial biopsies obtained from
cardiac transplant patients. These cells are cardiogenic
in vitro and have been shown to promote cardiac
regeneration and improve cardiac function in a nude
mouse infarct model. These observations provide hope
for adult heart-derived stem cell therapy in patients with
ischemia and chronic heart failure. It is not yet
clear whether the yield of ckitþ cells from cardiac
tissue is influenced by disease severity or risk factors
in patients with chronic coronary artery disease.
Therefore, we examined the effects of patient character-
istics, including coronary artery disease severity and risk
factors, on the yield of ckitþ cells from adult human
heart.
PATIENTS AND METHODS
The study group comprised 30 patients aged 38–72 years
who had undergone coronary artery bypass grafting at
our institute (Table 1). The study was approved by the
institutional ethics committee, and right atrial samples
were obtained from patients after obtaining their
informed consent. Cardiovascular risk factors were
defined as follows. Smoking was a history of smoking
for more than 2 years. Hypertension was repeatedly
elevated blood pressure with systolic pressure
4140 mm Hg and diastolic pressure 490 mm Hg for
more than 1 year. Diabetes was the need for oral anti-
diabetic drug therapy or insulin use. Dyslipidemia was
Chandrasekharan C Kartha, MD Tel: þ91 471 2524608 Fax: þ91 471 2446433 Email: cckartha@yahoo.com
Division of Cellular & Molecular Cardiology, Sree Chitra Tirunal Institute for Medical Sciences and Technology,
Thiruvananthapuram – 695011, India.
doi: 10.1177/0218492309103292
 SAGE Publications 2009 Los Angeles, London, New Delhi and Singapore
2009, VOL. 17, NO. 2 ASIAN CARDIOVASCULAR & THORACIC ANNALS139
 by on October 16, 2010 asianannals.ctsnetjournals.orgDownloaded from 
defined as low density lipoprotein4130 mgdL1, high
density lipoprotein <40 mgdL1, triglycerides
4150 mgdL1, and total cholesterol 4200 mgdL1.
The total vascular risk score was calculated for each
patient by considering hypertension, diabetes, smoking,
and dyslipidemia, as reported earlier.3 Patients were
grouped depending on the presence or absence of indivi-
dual risk factors as well as according to the severity of
coronary artery occlusion (number of affected coronary
arteries assessed during coronary angiography), func-
tional class, mitral regurgitation, wall motion abnorm-
alities, total vessel blockage, involvement of the right
coronary artery, and intake of drugs. The clinical profile
of the study group is given in Table 1.
Cardiac stem cells were isolated by a nonenzymatic
method.4 Right atrial biopsies were collected in ice-cold
buffer immediately after surgery, minced, and cultured
as explants on 2% gelatin-coated dishes. The cells that
migrated from the explants were collected by trypsin-
EDTA treatment, suspended in a growth-factor-supple-
mented medium, and grown in poly-D-lysine-coated
culture dishes (BD Biosciences, San Jose, CA, USA).
The migrated cells were characterized by the expression
of stem cell markers by fluorescent-activated cell sorting
(FACS) analysis. The antibodies used to confirm stem
cell identity were anti-human CD117 and MDR 1 mouse
monoclonals (Santa Cruz Biotechnology, CA, USA).
The antibodies were added to collected cells and
incubated for 30 min at 4C. After washing with cold
phosphate buffered saline, the cells were incubated with
fluorescence marker conjugated anti-mouse secondary
antibody (Molecular Probes, Leiden, The Netherlands)
for 30 min at 4C in the dark. The cells were further
washed with phosphate buffered saline, fixed with 4%
paraformaldehyde, and quantitative analysis was per-
formed on a 4-color multiparameter flow cytometer
(FACS Aria; Becton Dickinson Immunocytometry
Systems, San Jose, CA, USA). The cells that migrated
from the explants were expanded in a growth-factor-
supplemented medium (IMDMþDulbecco’s modified
Eagle’s Media-Ham’s F-12 mix; Sigma-Aldrich,
St. Louis, MI, USA) supplemented with 2-mercap-
toethanol 0.1 mmolL1, epidermal growth factor
10 ngmL1, basic fibroblast growth factor 20 ngmL1
(US Biologicals, Swampscott, MA, USA), 2% B27
serum supplement (Invitrogen, Grand Island, NY, USA),
thrombin 40 nmolL1 (Sigma-Aldrich, St Louis, MI,
USA), benzyl penicillin 100 UmL1, streptomycin
100 mgmL1, and L-glutamine 2 mmolL1.5 After
48 h of culture, cardiospheres were collected and
dissociated by trypsin-EDTA treatment. The cells
obtained were analyzed by FACS for expression of
stem cell markers such as ckit, MDR1, and CD34, as
well as cardiac differentiation markers cTNI and MHC
(Santa Cruz Biotechnology, CA, USA). The clinical
parameters of the patients were analyzed for their role in
determining the number of ckitþ cells migrating from
the explants.
Data are expressed as mean standard deviation.
Comparisons of means among groups were performed
by one-way analysis of variance. Bivariate correlation
and single linear regression were undertaken to assess
the relationship between cardiac stem cell counts and
age. A p value of 0.05 or less was considered statistically
significant.
RESULTS
Small round phase-bright cells were seen migrating
from adherent tissue explants grown from right atrial
samples collected from all patients in the study. The
cells formed cardiospheres when grown in a medium
supplemented with growth factors. These cells stained
positive for ckit and MDR1 in FACS. However,
the number of migrated cells varied significantly
among the explant cultures. Cardiosphere-derived cells
stained positively for ckit, MDR1, CD34, and the
cardiac differentiation markers cTNI and MHC.4
Table 1. Clinical characteristics of 30 patients undergoing
coronary artery bypass
Variable % of Patients
Age (years) 54.87 8.9
Male/female 26:4
Risk factors
Smoking 40%
Hypertension 60%
Diabetes mellitus 70%
Dyslipidemia 53%
Coronary artery disease
1-vessel 3%
2-vessel 30%
3-vessel 66%
NYHA class
I 0%
II 83%
III 16%
Mitral regurgitation
0 26%
1 46%
2 26%
RWMA 46%
Totally blocked vessels 46%
Right coronary artery blockage 23%
Statin 40%
Beta blocker 90%
Aspirin 20%
Ca-channel blocker 16%
Nitrates 80%
NYHA¼New York Heart Association, RWMA¼ regional
wall motion abnormality.
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Cardiovascular risk factors and other clinical parameters
did not seem to affect the number of ckitþ cells
migrating from explanted atrial tissue samples. The
number of migrating cells was also unaffected by any of
the drugs taken by the patients (Table 2). Among the
various clinical parameters analyzed, only the age of the
patient had a statistically significant relationship with
the stem cell number (p 0.05, r¼0.419; Figure 1).
DISCUSSION
Recent animal studies and clinical trials have reported
the scope of heart-resident ckitþ stem cells in
regenerating infarcted myocardium. The determinants
of successful isolation of such cells are however
unknown. The evidence reported here suggests that
coronary artery disease and cardiac remodeling in
chronic ischemia may not affect the yield of ckitþ
cells from atrial tissue. Our findings support current
pursuits in developing cardiac regenerative therapy in
patients with coronary artery disease, using autologous
stem cells isolated and grown from cardiac biopsies.
Embryonic stem cells, bone marrow-derived stem cells,
mesenchymal stem cells, skeletal myoblasts, and circu-
lating endothelial progenitor cells have all been assessed
for myocardial regeneration, both in animals and
humans.6–9 Recently, it has been demonstrated that
ckitþ cells isolated from small myocardial samples
(so-called cardiac stem cells) are also possibly capable
of efficient myocardial repair.10 Compared to other cell
types, autologous adult cardiac stem cells are considered
more efficient in rebuilding damaged myocardium.11
They have the advantage of being non-immunogenic,
and they might not undergo malignant transformation as
may happen with cells derived from embryos. Anversa
and colleagues12 showed that stem cells isolated from
cardiac biopsies are functionally competent and grow
in vivo when grafted into a recipient heart, thus
indicating the therapeutic possibilities of using car-
diac-derived stem cells in myocardial ischemia or end-
stage heart disease. Be that as it may, several issues
remain to be clarified before the clinical utility of heart-
derived stem cells is accepted.13 Among these is the
concern that the population of resident stem cells in
cardiac tissue may be affected by the factors responsible
for coronary artery disease or myocardial disease.
Alterations, if any, in the population of stem cells in
the heart would influence the success of stem cell
isolation from cardiac biopsies, and thus hamper the
clinical utility of such treatment. Our findings embolden
the efforts to develop a strategy for myocardial
Table 2. Clinical parameters and results of analysis
of variance
Variables
No. of
Patients Mean SD p Value
Male 26 7.76 6.42 0.84
Female 4 8.46 6.72
Smoker 12 6.94 4.55 0.52
Nonsmoker 18 8.47 7.36
Hypertension 18 8.33 5.6 0.62
No hypertension 12 7.15 7.49
Diabetes 21 7.52 7.00 0.67
No diabetes 9 8.63 4.72
Dyslipidemia 16 7.68 5.75 0.87
No dyslipidemia 14 8.06 7.17
TVRS 1 7 9.36 9.20
TVRS 2 9 6.64 5.11 0.69
TVRS 3 10 9.26 6.12
TVRS 4 3 4.27 2.87
NYHA class II 25 7.96 6.36 0.84
NYHA class III 5 7.32 6.93
2-vessel disease 9 4.76 4.02 0.15
3-vessel disease 20 9.44 6.83
RWMA 14 8.90 6.42 0.41
No RWMA 16 6.94 6.33
Mitral regurgitation
grade 0
8 9.33 9.42
Mitral regurgitation
grade 1
14 5.41 3.14 0.12
Mitral regurgitation
grade 2
8 10.67 6.00
Totally blocked vessel 14 6.70 6.13 0.36
No totally blocked vessel 16 8.86 6.54
RCA involvement 7 6.61 6.05 0.56
No RCA involvement 23 8.23 6.51
Statin user 12 6.16 5.08 0.23
Nonuser 18 8.99 6.97
-blocker user 27 8.52 6.34 0.08
Nonuser 3 1.89 0.75
Nitrates user 24 6.88 5.12 0.09
Nonuser 6 11.77 9.47
Ca-channel blocker user 5 3.80 1.93 0.12
Nonuser 25 8.66 6.63
NYHA¼New York Heart Association, RCA¼ right coronary
artery, RWMA¼ regional wall motion abnormality,
SD¼ standard deviation, TVRS¼ total vascular risk score.
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Figure 1. Single linear regression plot of age vs. cardiac
stem cell counts.
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regeneration in patients with coronary artery disease,
using autologous stem cells isolated from cardiac
biopsies.
Our observations are interesting given the contrasting
observations on circulating endothelial progenitor cells.
There is increasing evidence that patients at risk of
coronary artery disease have decreased numbers of
circulating progenitor cells, and thus impaired vasculo-
genesis.14,15 Cardiovascular risk factors and the number
of stenosed coronary arteries also seem to relate to the
formation of functional circulating progenitor cells in
culture.16,17 A decline in endothelial progenitor cell
number and function with age has been reported.18 This
was attributed to loss of functional telomeres in the
absence of telomerase activity, which is a major cause of
loss of proliferative capacity in mammalian cells.19,20
Our data illustrate a similar significant inverse correla-
tion between patient age and cardiac stem cell yield
from atrial biopsies. This suggests that in older patients,
stem cell isolation from cardiac biopsies may not
succeed, and such cells may not be available to them
for cell therapy.
We have provided evidence for the first time that the
yield of stem cells from cardiac biopsies is not
influenced by either disease severity or risk factors for
coronary artery disease. Except in older patients,
isolation of stem cells from adult heart tissue could
provide an avenue for developing regenerative cell
therapy in patients with coronary artery disease.
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